A Comparative Data Set Showcasing MatriClone Matrices for iPSCs

For this month’s reagent round up, I would like to share a comparative data set showcasing our MatriClone matrix.

MatriClone is an exciting opportunity for customers looking to accelerate their cell therapy workflows and deliver new treatments to market. For those who are not familiar with the matrix, it is comprised of truncated recombinant Laminin-511 protein and is designed to support the health and pluripotency of induced pluripotent stem cells (iPSCs). Unlike most iPSC matrices, MatriClone is optically suited for whole well imaging required for regulatory approval and is soluble, meaning that pre-coating of plates is no longer required!